OncoCyte
$3.2
24
+$0.47+17.22% Tuesday 20:00
Statistics
Day High
3.2
Day Low
2.71
52W High
4.75
52W Low
1.92
Volume
99,941
Avg. Volume
43,741
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
18MayExpected
Expected EPS
-0.2425
Actual EPS
N/A
Financials
-3,225.04%Profit Margin
Unprofitable1.88MRevenue
-60.66MNet Income
Analyst Ratings
$10.50Average Price Target
The highest estimate is 12.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow OCX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Guardant Health
GH
Mkt Cap11.72B
Exact Sciences
EXAS
Mkt Cap12.25B
Fulgent Genetics
FLGT
Mkt Cap687.17M
Bionano Genomics
BNGO
Mkt Cap17.42M
Pacific Biosciences of California
PACB
Mkt Cap702.87M
Illumina
ILMN
Mkt Cap18.99B
CRISPR Therapeutics
CRSP
Mkt Cap5.82B
Natera
NTRA
Mkt Cap27.3B
About
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies. The company has a collaboration agreement with Life Technologies Corporation to develop and collaborate in the commercialization of Oncomine Comprehensive Assay Plus and Determa IO assay for use with Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.
Show more...
CEO
Mr. Joshua Riggs
Employees
46
Country
US
ISIN
US68235C1071
Listings
0 Comments
Share your thoughts
FAQ
What is OncoCyte stock price today?▼
The current price of OCX is $3.2 USD — it has increased by +17.22% in the past 24 hours. Watch OncoCyte stock price performance more closely on the chart.
What is OncoCyte stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange OncoCyte stocks are traded under the ticker OCX.
Is OncoCyte stock price growing?▼
OCX stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year OncoCyte has showed a +8.47% increase.
What is OncoCyte revenue for the last year?▼
OncoCyte revenue for the last year amounts to 1.88M USD.
What is OncoCyte net income for the last year?▼
OCX net income for the last year is -60.66M USD.
How many employees does OncoCyte have?▼
As of April 02, 2026, the company has 46 employees.
In which sector is OncoCyte located?▼
OncoCyte operates in the Health Care sector.
When did OncoCyte complete a stock split?▼
The last stock split for OncoCyte was on July 25, 2023 with a ratio of 1:20.
Where is OncoCyte headquartered?▼
OncoCyte is headquartered in Irvine, US.